Van Oene Mark 4
4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Pacific Biosciences (PACB) COO Mark Van Oene Sells Shares
What Happened
Mark Van Oene, Chief Operating Officer of Pacific Biosciences (PACB), sold 129,790 shares on 2026-02-17 and 55,107 shares on 2026-02-18, for reported proceeds of $204,549 and $89,769 respectively (total 184,897 shares for ~$294,318). The transactions are reported as sales (open market/private sale). Footnote F1 states these sales include shares mandatorily sold to cover tax withholding in connection with RSU vesting.
Key Details
- Transaction dates & prices:
- 2026-02-17: 129,790 shares at a weighted average $1.58 (filing notes sale prices ranged $1.51–$1.68) — $204,549.
- 2026-02-18: 55,107 shares at a weighted average $1.63 (filing notes sale prices ranged $1.55–$1.70) — $89,769.
- Total sold: 184,897 shares for ~$294,318.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Notable footnotes:
- F1: Shares mandatorily sold to cover tax withholding for RSU vesting.
- F2 / F4: Reported sale prices are weighted averages across price ranges; issuer or filer can provide per-price breakdown on request.
- F3: Notes inclusion of 7,500 shares purchased under the company ESPP on 2025-09-02.
- Filing timeliness: Reported transaction date 2026-02-17; Form 4 filed 2026-02-19 (within the typical 2-business-day window).
Context
These were sales — including tax-withholding sales tied to RSU vesting — which are common and do not necessarily signal a change in executive confidence. For retail investors, purchases by insiders often convey clearer bullish signals; this filing documents routine liquidity/tax-related sales rather than an acquisition or exercise-based change in ownership.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-02-17$1.58/sh−129,790$204,549→ 1,797,745 total - Sale
Common Stock
[F1][F4][F3]2026-02-18$1.63/sh−55,107$89,769→ 1,742,638 total
Footnotes (4)
- [F1]Represents the number of shares mandatorily sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This sale price represents the weighted average sale price of the shares sold ranging from $1.51 to $1.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Includes 7,500 shares purchased on September 2, 2025 under the Company's 2010 Employee Stock Purchase Plan.
- [F4]This sale price represents the weighted average sale price of the shares sold ranging from $1.55 to $1.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.